Delivery Order SPE2DR25D1109-SPE2DR26FFH3L
- Not listed
- AmerisourceBergen Drug Corp was awarded a $41,916 firm fixed price delivery order by the Defense Logistics Agency (DLA) for Rabavert rabies vaccine with diluents, with an ultimate completion date of June 3, 2025. The non-set-aside, competitively awarded contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and aligns with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,095.80 by the Defense Logistics Agency for the supply of Rabavert rabies vaccine with diluents. This contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price transaction with no set-aside designation. The award was competitively procured and reflects AmerisourceBergen's ongoing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Rabavert rabies vaccine with diluents. The contract, awarded on October 28, 2025, carries a ceiling value of $1,257.48 under firm fixed pricing with an ultimate completion date of October 29, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for Rabavert rabies vaccine with diluents valued at $3,246.40. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract represents a small-value transaction for critical medical supplies supporting federal healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 16, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price delivery order, valued at $62,874.00, is scheduled for completion by July 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at the company's corporate office location in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $10,479.00 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $29,477.60 to AmerisourceBergen Drug Corp for RABAVERT rabies vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025, just one day after the award date of November 20, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH3LDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,572.68 by the Defense Logistics Agency for the supply of Rabavert rabies vaccine with diluents. The contract, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of vaccines, specialty medications, and medical supplies to support defense healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen competes effectively in open federal procurement to supply medical products across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/2/25 |